Kibbutz Yotvata, Brevel sign agreement to build manufacturing facility for microalgae-based alternative protein

The facility will house a fermentation reactor sized at 30,000 L, which is the largest of its kind. This will allow the total manufacturing volume reach up to 900,000 L.

Israel-based Kibbutz Yotvata and Brevel signed an agreement to build a commercial-scale manufacturing facilityfor cultivating and producingmicroalgae-based protein and other products for the food and beverage industry. The facility will house a fermentation reactor sized at 30,000 L, which is the largest of its kind. This will allow the total manufacturing volume reach up to 900,000 L and 3,000 tons of dry product per year; an upgrade from Brevel’s current fermenters that have a capacity of 5,000 L. Once the facility is completed, the parties expect to export to customers abroad at least 25% of its production to various markets.

“We are proud to build the largest facility of its kind in the world, which will be producing microalgae on a commercial scale to support rising demand in various markets,” said Hannan Shushan, Yotvata's CEO, in a press release. “Yotvata is dedicated towards finding sustainable solutions to feed the ever-growing world population and believes that the alternative-protein market will play a big part in that mission. The agreement with Brevel is a significant step in that direction.”

Yonatan Golan, CEO and co-founder of Brevel, said the agreement is a milestone for microalgae-based alternative protein. “This first commercial scale manufacturing facility will enable us to move our vision forward: to become the number one choice for plant-based protein worldwide,” Golan said. “We are actively working to solve the biggest nutrition challenges that exist today. The company is achieving this by providing truly sustainable plant-based protein, which is both color and flavor neutral, and available for the first time at an affordable cost for the food industry.”